ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
Marti
Gerald
G
FDA, Bethesda, MD 20892, USA. gemarti@helix.nih.gov
Orfao
Alberto
A
Goolsby
Chuck
C
D014408:Biomarkers, Tumor / Q000032:analysis* / Q000592:standards; D005434:Flow Cytometry / Q000379:methods* / Q000592:standards*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000032:analysis* / Q000592:standards
D014408:Biomarkers, Tumor; D051746:ZAP-70 Protein-Tyrosine Kinase; C497261:ZAP70 protein, human